Revolution Medicines (RVMD) Return on Sales (QoQ) (2019 - 2024)

Revolution Medicines (RVMD) Return on Sales (QoQ) (2019 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 -64.00
Jun 30, 2024 -598.00
Mar 31, 2024 116.00
Dec 31, 2023 -210.00
Sep 30, 2023 13.00
Jun 30, 2023 -16.00
Mar 31, 2023 -6.00
Dec 31, 2022 18.00
Sep 30, 2022 -15.00
Jun 30, 2022 1.00
Mar 31, 2022 -2.00
Dec 31, 2021 43.00
Sep 30, 2021 -43.00
Jun 30, 2021 -1.00
Mar 31, 2021 0.00
Dec 31, 2020 -2.00
Sep 30, 2020 1.00
Jun 30, 2020 -1.00
Mar 31, 2020 0.00
Dec 31, 2019 -1.00